Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Vertex Stock Up 40 Percent After Cystic Fibrosis Trial Results 06/24/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
New Data Could Open Vertex’s CF Drug to 400 More Patients 07/29/13 Boston
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Vertex Pharmaceuticals Booms on Cystic Fibrosis Combo Drug Study 04/18/13 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More 05/10/12 San Diego
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again 10/27/11 Boston
Page 1 of 1